Spotlight on Faricimab in the Treatment of Wet Age-Related Macular Degeneration: Design, Development and Place in Therapy

The advent of anti-vascular endothelial growth factor (VEGF) agents has revolutionized the treatment of retinal neovascular diseases including neovascular age-related macular degeneration (nAMD), a leading cause of irreversible blindness. Multiple agents and methods for drug delivery are emerging to...

Descripción completa

Detalles Bibliográficos
Autores principales: Nair, Archana A, Finn, Avni P, Sternberg Jr, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529225/
https://www.ncbi.nlm.nih.gov/pubmed/36199631
http://dx.doi.org/10.2147/DDDT.S368963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529225/
https://www.ncbi.nlm.nih.gov/pubmed/36199631
http://dx.doi.org/10.2147/DDDT.S368963

Ejemplares similares